Dermatophytic
onychomycosis, also known as tinea unguium, is a fungal disease of
toenails or fingernails that causes ring infection over nails.
Trichophyton rubrum and trichophyton mentagrophytes are common
strains of fungi responsible for causing dermatophytic onychomycosis.
Furthermore, yeasts and non-dermatophyte molds are other agents that
spread the infection. Public places such as gym, swimming pool, and
others that are infected with disease causing fungal agents are major
source, which cause dermatophytic onychomycosis. Moreover, continuous
use of shoes for a longer duration and contact of toe nail with wet
surface causes the fungal infection. Increasing incidences of the
infection are evident in sportsperson, owing to continuous use of
shoe, sweating at nails, and traumatic nail injuries.
Get
PDF Brochure for Research Insights @
https://www.coherentmarketinsights.com/insight/request-sample/2053
Major
symptoms of dermatophytic onychomycosis include thickening and
whitening of nails. Moreover, the nails become brittle and appear
white as the infection progresses. People suffering from diabetes,
peripheral vascular disease, HIV, immune suppression, obesity, and
geriatric population are at increased risk of this common fungal
infection. Dermatophytic onychomycosis could be treated with either
topical preparations or oral antifungal agents based on the severity
of infection. The treatment often lasts for an average period of six
months. In recent past, advancement in therapy with the introduction
of effective topical and oral products has controlled the rapid
spread of dermatophytic onychomycosis.
The
global dermatophytic onychomycosis treatment market size was valued
at US$ 2,596.8 million in 2017, and is expected to witness a CAGR of
12.6% over the forecast period (2018 – 2026).
Increased
global prevalence of dermatophytic onychomycosis is expected to
propel growth of the dermatophytic onychomycosis treatment market
Dermatophytic
onychomycosis is most common nail disorder. According to a report in
the Journal of Cutaneous Medicine and Surgery, 2017, onychomycosis
accounts for 50% of all nail diseases and prevalence of onychomycosis
was estimated to be 5.5% with margin of error of + 3% worldwide.
Prophylactic use of topical antifungal agent is expected to aid in
effective treatment of dermatophytic onychomycosis, which in turn is
major factor contributing to the market growth.
Development
of new therapies that aid in treatment of dermatophytic onychomycosis
is expected to drive growth of the dermatophytic onychomycosis
treatment market over the forecast period
Introduction
of new drug candidates and adoption of new treatment approaches is a
major factor contributing to the dermatophytic onychomycosis
treatment market growth. For instance, in 2014, the U.S. Food and
Drug Administration (FDA) approved two new topical antifungal
drugs—efinaconazole and tavaborole— for the treatment of
dermatophytic onychomycosis caused by Trichophyton rubrum and
Trichophyton mentagrophytes. Efinaconazole is the first approved
topical triazole antifungal agent and tavaborole is the first
approved oxobarole antifungal agent for this indication. These agents
offer short treatment courses, high cure rates, and few relapse
cases.
Key
players operating in the dermatophytic onychomycosis treatment market
include, Bausch Health Companies, Galderma S.A., Celtic Pharma,
Anacor pharmaceuticals, Inc., Johnson & Johnson, Novartis AG,
Pfizer Inc., GlaxoSmithKline, Topica Pharmaceuticals, Inc., Moberg
Pharma AB, Bayer AG, Dr. Reddy’s Laboratories Ltd, Allergen, Inc.,
Cipla Ltd, Medimetriks Pharmaceuticals Inc., Sanofi S.A., NovaBiotics
Inc., and Merz Pharma.
Detailed
Segmentation:
Global
Dermatophytic Onychomycosis Treatment Market, By Therapy Type:
-
Systemic Therapy
-
Topical Therapy
-
Device-based Therapy
Global
Dermatophytic Onychomycosis Treatment Market, By End User:
-
Hospitals
-
Dermatology Clinics
-
Retail Pharmacies
-
Others
Global
Dermatophytic Onychomycosis Treatment Market, By Geography:
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
Get
Full Access of This Business Report:
https://www.coherentmarketinsights.com/market-insight/dermatophytic-onychomycosis-treatment-market-2053
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
